SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-040396
Filing Date
2022-11-08
Accepted
2022-11-08 07:15:08
Documents
13
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20005640x2_8k.htm   iXBRL 8-K 26372
2 EXHIBIT 99.1 ny20005640x2_ex99-1.htm EX-99.1 106468
  Complete submission text file 0001140361-22-040396.txt   284588

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avro-20221108.xsd EX-101.SCH 3863
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20221108_lab.xml EX-101.LAB 23291
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20221108_pre.xml EX-101.PRE 16551
7 EXTRACTED XBRL INSTANCE DOCUMENT ny20005640x2_8k_htm.xml XML 4383
Mailing Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139 617.914.8420
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 221367200
SIC: 2836 Biological Products, (No Diagnostic Substances)